Literature DB >> 22903045

Antisense therapeutics: Nuclear RNA more susceptible to knockdown.

Man Tsuey Tse.   

Abstract

Year:  2012        PMID： 22903045     DOI： 10.1038/nrd3825

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

Review 1.  Targeting RNA to treat neuromuscular disease.

Authors:  Francesco Muntoni; Matthew J A Wood
Journal:  Nat Rev Drug Discov       Date:  2011-08-01       Impact factor: 84.694

2.  Targeting nuclear RNA for in vivo correction of myotonic dystrophy.

Authors:  Thurman M Wheeler; Andrew J Leger; Sanjay K Pandey; A Robert MacLeod; Masayuki Nakamori; Seng H Cheng; Bruce M Wentworth; C Frank Bennett; Charles A Thornton
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962
  2 in total
  4 in total

1.  Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro.

Authors:  Anne Sadewasser; Erik Dietzel; Sven Michel; Michael Klüver; Markus Helfer; Tamara Thelemann; Richard Klar; Markus Eickmann; Stephan Becker; Frank Jaschinski
Journal:  Mol Ther Nucleic Acids       Date:  2019-04-25

Review 2.  Gene regulation by the act of long non-coding RNA transcription.

Authors:  Aleksandra E Kornienko; Philipp M Guenzl; Denise P Barlow; Florian M Pauler
Journal:  BMC Biol       Date:  2013-05-30       Impact factor: 7.431

3.  New insights into transcription fidelity: thermal stability of non-canonical structures in template DNA regulates transcriptional arrest, pause, and slippage.

Authors:  Hisae Tateishi-Karimata; Noburu Isono; Naoki Sugimoto
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

4.  Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis.

Authors:  Lovorka Stojic; Aaron T L Lun; Jasmin Mangei; Patrice Mascalchi; Valentina Quarantotti; Alexis R Barr; Chris Bakal; John C Marioni; Fanni Gergely; Duncan T Odom
Journal:  Nucleic Acids Res       Date:  2018-07-06       Impact factor: 16.971
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.